Intrapleural treatment in patients with non‐small cell lung cancer with malignant pleural effusions in the real world-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intrapleural treatment in patients with non‐small cell lung cancer with malignant pleural effusions in the real world

Published:2021-11-06 Issue:24 Volume:12 Page:3416-3425
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Pan Pengfei¹^ORCID,Wu Fengjuan²,Xu Zhiyun³,Ji Xiang⁴,Qi Qian⁴,Huang Xiaomin¹,Zhao Ruyue¹,Liu Mingtao⁵,Jiang Peng⁶,Li Yu³^ORCID,Xu Lisheng³

Affiliation:

1. Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine Shandong University Jinan China

2. Department of Pulmonary and Critical Care Medicine Heze Municipal Hospital Heze China

3. Department of Pulmonary and Critical Care Medicine Qilu Hospital of Shandong University Jinan China

4. Department of Pulmonary and Critical Care Medicine Qianfoshan Hospital of Shandong First Medical University Jinan China

5. Department of Pulmonary and Critical Care Medicine Binzhou People's Hospital Binzhou China

6. Department of Pulmonary and Critical Care Medicine Weihai Municipal Hospital Weihai China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14224

Reference31 articles.

1. Cancer statistics in China, 2015

2. Pleural Effusion in Lung Cancer: More Questions than Answers

3. Malignant Pleural Effusion: Medical Approaches for Diagnosis and Management

4. ERS/EACTS statement on the management of malignant pleural effusions

5. Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management strategies for recurrent pleural effusion: a clinical practice review;AME Medical Journal;2023-12

2. Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma;Translational Lung Cancer Research;2023-09

3. Current Status and Progress in the Treatment of Malignant Pleural Effusion in Lung Cancer;Advances in Clinical Medicine;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3